venetoclax plus azacitidine in treatment-naïve and r/r mds
Published 3 years ago • 94 plays • Length 3:51Download video MP4
Download video MP3
Similar videos
-
4:04
venetoclax plus azacitidine in treatment-naïve hr-mds
-
5:36
venetoclax and azacitidine in mds patients
-
8:54
venetoclax plus azacitidine in treatment-naïve higher-risk mds
-
2:18
phase ib study of venetoclax plus azacitidine in patients with r/r mds
-
3:03
venetoclax and 5-azacytidine for the treatment of mds and cmml
-
5:52
venetoclax in combination with azacitidine for patients with treatment-naïve hr-mds
-
1:46
tagraxofusp combined with azacitidine and venetoclax in the treatment of bpdcn and aml
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
3:09
bleximenib combined with venetoclax and azacitidine in r/r aml with kmt2a or npm1 alterations
-
3:01
what is chronic myelomonocytic leukeia
-
2:19
the addition of venetoclax to hyper-cvad-nelarabine and pegylated asparagine in t-all
-
3:07
phase iii verona study of venetoclax with azacitidine in treatment-naïve higher-risk mds
-
3:17
venetoclax with azacitidine in hr-mds
-
0:44
predictors of poor response to azacitidine, venetoclax, and magrolimab in tp53-mutated aml
-
6:58
venetoclax plus azacitidine for higher-risk mds
-
2:20
pevonedistat, azacitidine and venetoclax triplet therapy for aml, mds and cmml
-
0:52
azacitidine in the treatment of mds
-
1:36
eprenetapopt plus venetoclax and azacitidine in the treatment of tp53-mutated aml
-
1:09
dec-c plus venetoclax in hr-mds and cmml: an analysis using different response criteria
-
2:45
imgn632 plus venetoclax and/or azacitidine for patients with cd123-positive aml
-
0:44
mds: an update on pevonedistat plus azacitidine
-
2:19
cladribine ldac venetoclax alternated with azacitidine venetoclax in older patients with aml